We stained the tumor tissue for CD31, TMR-Dextran, and ZO-1 to examine the effects of CSF-1R inhibition on TMEM doorway activity and vascular junctional integrity (Fig. 4A). The gene discussed is CSF1R; the disease is neoplasm.